121 related articles for article (PubMed ID: 2569812)
1. Effects of norakin on respiratory syncytial virus in tissue culture and in mice.
Mentel R; Schroeder C; Döhner L
Acta Virol; 1989 Mar; 33(2):162-6. PubMed ID: 2569812
[TBL] [Abstract][Full Text] [Related]
2. Treatment of human respiratory syncytial virus infected Balb/C mice with the proteasome inhibitor bortezomib (Velcade, PS-341) results in increased inflammation and mortality.
Lupfer C; Patton KM; Pastey MK
Toxicology; 2010 Jan; 268(1-2):25-30. PubMed ID: 19931343
[TBL] [Abstract][Full Text] [Related]
3. DSCG reduces RSV-induced illness in RSV-infected mice.
Hashimoto K; Mori S; Hashimoto Y; Kaneko H; Ishibashi K; Ishioka K; Kawasaki Y; Peebles RS; Munakata M; Hosoya M; Suzutani T
J Med Virol; 2009 Feb; 81(2):354-61. PubMed ID: 19107959
[TBL] [Abstract][Full Text] [Related]
4. Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model.
Gualdi L; Mertz S; Gomez AM; Ramilo O; Wittke A; Mejias A
Antiviral Res; 2013 Aug; 99(2):188-95. PubMed ID: 23735300
[TBL] [Abstract][Full Text] [Related]
5. [Effects of Alternanthera philoxeroides Griseb against respiratory syncytial virus infection in mice].
Jiang WL; Yang ZQ; Chen W; Xiao H; Luo XL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan; 27(1):62-4. PubMed ID: 17259148
[TBL] [Abstract][Full Text] [Related]
6. [In vitro inhibitory mechanism of respiratory syncytial virus with solution prescription of zhidanhuayu].
Liu YH; Hou AC; Zhao GC
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):486-7. PubMed ID: 19544654
[TBL] [Abstract][Full Text] [Related]
7. RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune response.
Zhang W; Tripp RA
J Virol; 2008 Dec; 82(24):12221-31. PubMed ID: 18818323
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of respiratory syncytial virus of subgroups A and B using deoxyribozyme DZ1133 in mice.
Zhou J; Yang XQ; Xie YY; Zhao XD; Jiang LP; Wang LJ; Cui YX
Virus Res; 2007 Dec; 130(1-2):241-8. PubMed ID: 17804108
[TBL] [Abstract][Full Text] [Related]
9. Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo.
Teng MN; Whitehead SS; Collins PL
Virology; 2001 Oct; 289(2):283-96. PubMed ID: 11689051
[TBL] [Abstract][Full Text] [Related]
10. Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy.
Bolger G; Lapeyre N; Dansereau N; Lagacé L; Berry G; Klosowski K; Mewhort T; Liuzzi M
Can J Physiol Pharmacol; 2005 Feb; 83(2):198-213. PubMed ID: 15791294
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by Norakin (triperiden) of Sindbis virus infection in mice.
Veckenstedt A; Güttner J; Schroeder C
Acta Virol; 1985 May; 29(3):209-15. PubMed ID: 2864821
[TBL] [Abstract][Full Text] [Related]
12. [Primary respiratory syncytial virus infection in mice].
Zou Y; Huang H; Xu J
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Aug; 24(8):484-6. PubMed ID: 11718040
[TBL] [Abstract][Full Text] [Related]
13. YM-53403, a unique anti-respiratory syncytial virus agent with a novel mechanism of action.
Sudo K; Miyazaki Y; Kojima N; Kobayashi M; Suzuki H; Shintani M; Shimizu Y
Antiviral Res; 2005 Feb; 65(2):125-31. PubMed ID: 15708639
[TBL] [Abstract][Full Text] [Related]
14. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
Ohol YM; Wang Z; Kemble G; Duke G
PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560
[TBL] [Abstract][Full Text] [Related]
15. Alteration of pulmonary macrophage function by respiratory syncytial virus infection in vitro.
Franke-Ullmann G; Pförtner C; Walter P; Steinmüller C; Lohmann-Matthes ML; Kobzik L; Freihorst J
J Immunol; 1995 Jan; 154(1):268-80. PubMed ID: 7995946
[TBL] [Abstract][Full Text] [Related]
16. A novel inhibitor of respiratory syncytial virus isolated from ethnobotanicals.
Ojwang JO; Wang YH; Wyde PR; Fischer NH; Schuehly W; Appleman JR; Hinds S; Shimasaki CD
Antiviral Res; 2005 Dec; 68(3):163-72. PubMed ID: 16280176
[TBL] [Abstract][Full Text] [Related]
17. An immunocompromised BALB/c mouse model for respiratory syncytial virus infection.
Kong X; Hellermann GR; Patton G; Kumar M; Behera A; Randall TS; Zhang J; Lockey RF; Mohapatra SS
Virol J; 2005 Feb; 2():3. PubMed ID: 15701174
[TBL] [Abstract][Full Text] [Related]
18. Palivizumab is highly effective in suppressing respiratory syncytial virus in an immunosuppressed animal model.
Ottolini MG; Curtis SR; Mathews A; Ottolini SR; Prince GA
Bone Marrow Transplant; 2002 Jan; 29(2):117-20. PubMed ID: 11850705
[TBL] [Abstract][Full Text] [Related]
19. Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo.
Miller AL; Bowlin TL; Lukacs NW
J Infect Dis; 2004 Apr; 189(8):1419-30. PubMed ID: 15073679
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene.
Zhang W; Yang H; Kong X; Mohapatra S; San Juan-Vergara H; Hellermann G; Behera S; Singam R; Lockey RF; Mohapatra SS
Nat Med; 2005 Jan; 11(1):56-62. PubMed ID: 15619625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
